1
/
of
1
FITC-Linked Polyclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)
TRV-024268-01
Antibodies
FITC-Linked Polyclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)
SKU:TRV-024268-01
Regular price
$341.60
Regular price
Sale price
$341.60
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
FITC-Linked Polyclonal Antibody to Suppression Of Tumorigenicity 14 (ST14) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
Related categories:
Antibodies
Share

Product specifications
| Alternative Name | SNC19; HAI; MT-SP1; PRSS14; TADG15; Epithin; Matriptase; Prostamin; Membrane-type serine protease 1; Serine protease 14; Tumor-associated differentially-expressed gene 15 |
| Name Synonym | Suppression Of Tumorigenicity 14 |
| Uniprot | AAH30532.1 |
| Field of Research | Tumor immunity |
| Applications | WB; IHC; ICC; IF. |
| Organism Species | Homo sapiens (Human) |
| Concentration | 500μg/mL |
| Buffer | PBS, pH7.4, containing 0.02% NaN3, 50% glycerol. |
| Host | 293F Cells |
| Source | Antibody labeling |
| Recommended Usage |
Western blotting: 0.2-2µg/mL;1:250-2500 Immunohistochemistry: 5-20µg/mL;1:25-100 Immunocytochemistry: 5-20µg/mL;1:25-100 Optimal working dilutions must be determined by end user. |